Antiangiogenic therapy with anti-vascular endothelial growth factor modalities for neovascular age-related macular degeneration

A new Cochrane Review assesses treatments to tackle one of the common reasons for vision loss when people get older. Magdalena Krzystolik from Providence in the United States describes what she and Satyanarayana S. Vedula found.